Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Barbara Bohn"'
Autor:
Barbara, Bohn, Peter, Bramlage, Christian, Wagner, Matthias, Kaltheuner, Reinhard, Welp, Stefan, Sziegoleit, Artur, Zimmermann, Hans Martin, Reuter, Michael, Hummel, Jörg, Gloyer, Reinhard W, Holl, Thomas, Danne
Publikováno v:
Wiener medizinische Wochenschrift (1946). 168(15-16)
Glargine U300 (Gla-300) is a further development of glargine U100 (Gla-100). Since 2015, Gla-300 has been available in Germany and Austria. We compared patients initiating therapy with Gla-300 with patients starting with Gla-100. Moreover, it was inv
Autor:
Katja Gollisch, Artur Zimmermann, Volker Zindel, Barbara Bohn, Sigrun Merger, Dpv Initiative, Christian Wagner, Desiree Dunstheimer, Florian Kopp, Reinhard W. Holl
Publikováno v:
Diabetes research and clinical practice. 129
Background The long-acting insulin analogue degludec is a therapeutic option for patients with type 1 (T1D) or type 2 diabetes (T2D). Aim of this analysis was to investigate differences in clinical characteristics of patients before and after initiat
Autor:
Martin Holder, Sabine E. Hofer, Klaus-Peter Otto, Barbara Bohn, Dpv Initiative, Wolfgang Kerner, Reinhard W. Holl, Beate Karges, Christian Vogel, Michaela Plamper, Martin Wabitsch, Elke Fröhlich-Reiterer, W. Marg
Publikováno v:
PLOS ONE 11(8), e0160971 (2016). doi:10.1371/journal.pone.0160971
PLoS ONE, Vol 11, Iss 8, p e0160971 (2016)
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0160971 (2016)
PLoS ONE
PLoS one 11(8), e0160971 (2016). doi:10.1371/journal.pone.0160971
Published by PLoS, Lawrence, Kan.
Published by PLoS, Lawrence, Kan.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4be6ad496a2d37fd80cf83bb6e91ee
Autor:
Martin Füchtenbusch, Wolfgang Kerner, Joachim Rosenbauer, Andreas Knauerhase, Jochen Seufert, Reinhard W. Holl, F Best, Martin Hofer, Hans-Peter Kempe, Peter M. Jehle, Barbara Bohn
Publikováno v:
Diabetes research and clinical practice. 115
Aims To analyse time trends of antihyperglycaemic therapy and glycaemic control in adult subjects with type 1, or type 2 diabetes between 2002 and 2014 in Germany/Austria. Methods 184,864 adults with diabetes (35,144 type 1 diabetes (T1D), 149,720 ty
Autor:
Dpv, Katharina Laubner, Peter M. Jehle, A Zimmermann, D Krakow, Apv initiatives, Stefan Zimny, Reinhard W. Holl, Nicole Scheuing, Barbara Bohn, S Merger, Michael Hummel, A Voll, B Born
Publikováno v:
Experimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 122(10)
Objective: Several studies suggest benefits of insulin analogues detemir or glulisine in overweight and obese patients with type 2 diabetes. The present multicentre study therefore examines, whether these insulin analogues are used more frequently in